Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opzelura
Pharma
Incyte posts mixed Opzelura results in prurigo nodularis
As Incyte strives to push Opzelura into new dermatology indications, the company’s latest data drop in prurigo nodularis is a bit of a mixed bag.
Fraiser Kansteiner
Mar 10, 2025 11:23am
Incyte provides first guidance for JAK cream Opzelura
Feb 10, 2025 2:25pm
Incyte eyes upcoming launches as Jakafi's patent cliff nears
Oct 29, 2024 5:07pm
Incyte picks Dr. Pimple Popper to expand Opzelura campaign
Oct 14, 2024 10:23am
Incyte finds fun in pharma ad fatigue in Opzelura TV spot
Aug 6, 2024 6:45am
Incyte touts 2 trial wins for PD-1 drug Zynyz amid I-O retreat
Jul 30, 2024 11:27am
